Dilevalol

CHEMBL27193 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

328.4 g/mol

LogP

3.1

Phase

4

A beta-blocker with additional vasodilating properties used to treat high blood pressure. It lowers blood pressure by reducing heart rate and relaxing blood vessels.

Berat Molekul

328,4000 g/mol

LogP

3,10

TPSA

95,60 Å²

Lipinski RO5

Lulus

Area Terapeutik

Stroke Obesity Hypertension

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1

InChI

InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)/t13-,18+/m1/s1

Molecular Formula

C19H24N2O3

HBD / HBA

4 / 4

Ikatan yang Dapat Dirotasi

8

Atom Berat

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A beta-blocker with additional vasodilating properties used to treat high blood pressure. It lowers blood pressure by reducing heart rate and relaxing blood vessels.

Yes, Dilevalol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL27193. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 134044. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Mencari informasi yang ramah bagi pasien?

Dilevalol di PillFYI

Struktur

Data Cepat

Rumus: C19H24N2O3

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.